$24.33 0.26 (+1.08%)
11/25/2009 2:13 PM

Par Pharmaceutical Companies, Inc. (PRX)

CAPS Rating: 2 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Featured Broker Partners